Nasal spray for heroin antidote under development

June 1, 2014 1:42 AM

5 0

Nasal spray for heroin antidote under development

CINCINNATI -- A Lexington, Ky., doctor has struck a critical agreement to get a life-saving product in the hands of emergency room workers and paramedics across the country as they battle the nation's heroin epidemic.

Dr. Daniel Wermeling, a professor of pharmacy at the University of Kentucky, has signed an agreement with Reckitt Benckiser Pharmaceuticals Inc. to accelerate production and marketing of intranasal naloxone, a drug designed to treat heroin and opioid overdose. The firm's U.S operations are headquart...

Read more

To category page

Loading...